Previous and ongoing ATMP activities
Uppsala is a strong hub for innovation where many research ideas are developed in both academia and industry. Uppsala University Hospital has long experience of treating patients with ATMP, both in clinical trials and commercial drugs.
Some of Uppsala University Hospital's and Uppsala University's previous and ongoing activities are presented below.
- AdVince - immunotherapy for neuroendocrine cancer
- Bacteriophages as treatment for prosthetic infections
- Extracellular vesicles from mesenchymal stromal cells for the treatment of inflammatory conditions
- CAR T cells – the first clinical trial in Europe
- Genetically modified islet cells as a treatment for type 1 diabetes
- LOAd – immunostimulatory gene therapy for cancer
- Placenta-derived stromal cells in severe acute GvHD
- Protrans - cell therapy for type 1 diabetes
- The CARMA study – treating lymphoma with new 'armed' CAR T cells
- Transplantation of keratinocytes (skin cells) for severe burn injuries